Lv33
374 积分 2023-11-06 加入
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
1个月前
已完结
A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors
1个月前
已完结
Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time
1个月前
已完结
SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial
1个月前
已完结
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
1个月前
已完结
Recent Advances in enhancer of zeste homolog 2 Inhibitors: Structural insights and therapeutic applications
1个月前
已完结
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
2个月前
已完结
Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents
2个月前
已完结
Recent advances in EZH2-based dual inhibitors in the treatment of cancers
2个月前
已完结
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
2个月前
已完结
皖公网安备34019202002308
